By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Anticholinergic antiemetics > Triptone > Dimenhydrinate Dosage
Anticholinergic antiemetics
https://themeditary.com/dosage-information/dimenhydrinate-dosage-4324.html

Dimenhydrinate Dosage

Drug Detail:Triptone (Dimenhydrinate [ dye-men-hye-dri-nate ])

Drug Class: Anticholinergic antiemetics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Motion Sickness

INJECTABLE: 50 to 100 mg IM or IV every 4 hours as needed; Maximum Dose: 400 mg within 24 hours.

ORAL:

  • Immediate Release: 50 to 100 mg every 4 to 6 hours as needed; Maximum Dose: 400 mg within 24 hours.
  • Extended Release: 100 mg every 8 to 12 hours as needed; Maximum Dose: 300 mg within 24 hours.

RECTAL: 50 to 100 mg every 6 to 8 hours as needed.

Use: Prevention and treatment of nausea, vomiting, dizziness, and/or vertigo associated with motion sickness.

Usual Adult Dose for Vertigo

INJECTABLE: 50 to 100 mg IM or IV every 4 hours as needed; Maximum Dose: 400 mg within 24 hours.

ORAL:

  • Immediate Release: 50 to 100 mg every 4 to 6 hours as needed; Maximum Dose: 400 mg within 24 hours.
  • Extended Release: 100 mg every 8 to 12 hours as needed; Maximum Dose: 300 mg within 24 hours.

RECTAL: 50 to 100 mg every 6 to 8 hours as needed.

Use: Prevention and treatment of nausea, vomiting, dizziness, and/or vertigo associated with motion sickness.

Usual Adult Dose for Nausea/Vomiting

INJECTABLE: 50 to 100 mg IM or IV every 4 hours as needed; Maximum Dose: 400 mg within 24 hours.

ORAL:

  • Immediate Release: 50 to 100 mg every 4 to 6 hours as needed; Maximum Dose: 400 mg within 24 hours.
  • Extended Release: 100 mg every 8 to 12 hours as needed; Maximum Dose: 300 mg within 24 hours.

RECTAL: 50 to 100 mg every 6 to 8 hours as needed.

Use: Prevention and treatment of nausea, vomiting, dizziness, and/or vertigo associated with motion sickness.

Usual Pediatric Dose for Motion Sickness

INJECTABLE:

  • Neonate: Contraindicated.
  • Older Than Neonate: 1.25 mg/kg OR 37.5 mg/m2 IM 4 times a day; Maximum Dose: 300 mg per day.

ORAL:
  • Under Age 2 Years: Not recommended.
  • Age 2 to 5 Years: 12.5 to 25 mg orally every 6 to 8 hours as needed; Maximum Dose: 75 mg within 24 hours.
  • Age 6 to 11 Years: 25 to 50 mg orally every 6 to 8 hours as needed; Maximum Dose: 150 mg within 24 hours.
  • Age 12 Years and Over: 50 to 100 mg orally every 4 to 6 hours as needed; Maximum Dose: 400 mg within 24 hours.

RECTAL:
  • Under Age 2 Years: Contraindicated.
  • Age 2 to 5 Years: 12.5 to 25 mg once; do not repeat dose except on the advice of a physician.
  • Age 6 to 7 Years: 12.5 to 25 mg every 8 to 12 hours as needed.
  • Age 8 to 11 Years: 25 to 50 mg every 8 to 12 hours as needed.
  • Age 12 Years and Over: 50 mg every 8 to 12 hours as needed.

Use: Prevention and treatment of nausea, vomiting, dizziness, and/or vertigo associated with motion sickness.

Usual Pediatric Dose for Vertigo

INJECTABLE:

  • Neonate: Contraindicated.
  • Older Than Neonate: 1.25 mg/kg OR 37.5 mg/m2 IM 4 times a day; Maximum Dose: 300 mg per day.

ORAL:
  • Under Age 2 Years: Not recommended.
  • Age 2 to 5 Years: 12.5 to 25 mg orally every 6 to 8 hours as needed; Maximum Dose: 75 mg within 24 hours.
  • Age 6 to 11 Years: 25 to 50 mg orally every 6 to 8 hours as needed; Maximum Dose: 150 mg within 24 hours.
  • Age 12 Years and Over: 50 to 100 mg orally every 4 to 6 hours as needed; Maximum Dose: 400 mg within 24 hours.

RECTAL:
  • Under Age 2 Years: Contraindicated.
  • Age 2 to 5 Years: 12.5 to 25 mg once; do not repeat dose except on the advice of a physician.
  • Age 6 to 7 Years: 12.5 to 25 mg every 8 to 12 hours as needed.
  • Age 8 to 11 Years: 25 to 50 mg every 8 to 12 hours as needed.
  • Age 12 Years and Over: 50 mg every 8 to 12 hours as needed.

Use: Prevention and treatment of nausea, vomiting, dizziness, and/or vertigo associated with motion sickness.

Usual Pediatric Dose for Nausea/Vomiting

INJECTABLE:

  • Neonate: Contraindicated.
  • Older Than Neonate: 1.25 mg/kg OR 37.5 mg/m2 IM 4 times a day; Maximum Dose: 300 mg per day.

ORAL:
  • Under Age 2 Years: Not recommended.
  • Age 2 to 5 Years: 12.5 to 25 mg orally every 6 to 8 hours as needed; Maximum Dose: 75 mg within 24 hours.
  • Age 6 to 11 Years: 25 to 50 mg orally every 6 to 8 hours as needed; Maximum Dose: 150 mg within 24 hours.
  • Age 12 Years and Over: 50 to 100 mg orally every 4 to 6 hours as needed; Maximum Dose: 400 mg within 24 hours.

RECTAL:
  • Under Age 2 Years: Contraindicated.
  • Age 2 to 5 Years: 12.5 to 25 mg once; do not repeat dose except on the advice of a physician.
  • Age 6 to 7 Years: 12.5 to 25 mg every 8 to 12 hours as needed.
  • Age 8 to 11 Years: 25 to 50 mg every 8 to 12 hours as needed.
  • Age 12 Years and Over: 50 mg every 8 to 12 hours as needed.

Use: Prevention and treatment of nausea, vomiting, dizziness, and/or vertigo associated with motion sickness.

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Patients with Hepatic Impairment: Use with caution.

Dose Adjustments

Pediatric Patients: Discontinue use if paradoxical excitation (restlessness, nervousness, hallucinations, delirium, and/or seizures) occurs.

Dialysis

Data not available.

Other Comments

Administration Advice:

  • INJECTABLE: Dilute before IV administration; consult the manufacturer product information for dilution instructions.
  • INJECTABLE: For IV administration, administer the drug slowly over 2 minutes.
  • INJECTABLE: Do not administer intra-arterially.
  • INJECTABLE: Inspect the drug visually for particulate matter and discoloration prior to administration.
  • ORAL: To prevent motion sickness, the first dose should be taken at least 30 minutes to 1 to 2 hours before starting activity.
  • RECTAL: For ease and comfort, smooth any edges prior to use.

Storage Requirements:
  • Consult the manufacturer product information.

IV Compatibility:
  • Consult the manufacturer product information.

General:
  • Some formulations of this drug may be available only as special order products compounded at pharmacies with patient-specific dosing.
  • Parenteral therapy is indicated when oral or rectal therapy is inappropriate.
  • OVERDOSAGE: There is no specific antidote; consult the manufacturer product information for possible treatment options.

Patient Advice:
  • If using this drug regularly, take a missed dose as soon as possible; however, skip the missed dose if it is almost time for the next dose.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by